The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
UnitedHealth Group (UNH) closed at $587.13 in the latest trading session, marking a +0.45% move from the prior day.
UnitedHealth's (UNH) expansion into targeted markets, strategic diversification and attractive dividends present significant growth opportunities.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $578.78, denoting a +0.19% change from the preceding trading day.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The recent cybersecurity glitch triggered by a global technological outage exposed the underlying cyber threat as the world continues to embrace internet technology. The cyber glitch came against the backdrop of the recent cyber attacks on UnitedHealth Group (NYSE: UNH ), MGM Resorts (NYSE: MGM ), and Caesars Entertainment (NASDAQ: CZR ), two major casino operators in the country.
UnitedHealth Group is positioned as a leader in the health services industry despite setbacks from a cyberattack and industry headwinds in 2024. The company's 2025 investment thesis is optimistic, with expectations of market share gains, margin improvements, and recovery for Optum Insight. UNH is expected to outperform in 2025, with the potential for revenue growth above estimates, leading to a price target of $640 per share.
UnitedHealth Group has markedly outperformed the S&P 500 since my last buy rating. The managed care company's revenue and adjusted diluted EPS climbed in the second quarter. UnitedHealth Group enjoys an A+ credit rating from S&P.